{"id":"https://openalex.org/W4406066347","doi":"https://doi.org/10.1016/s0022-3565(24)29584-7","title":"Pharmacological Evidence for a 7-Benzylidenenaltrexone-Preferring Opioid Receptor Mediating the Inhibitory Actions of Peptidic \u03b4- and \u03bc-Opioid Agonists on Neurogenic Ion Transport in Porcine Ileal Mucosa","display_name":"Pharmacological Evidence for a 7-Benzylidenenaltrexone-Preferring Opioid Receptor Mediating the Inhibitory Actions of Peptidic \u03b4- and \u03bc-Opioid Agonists on Neurogenic Ion Transport in Porcine Ileal Mucosa","publication_year":2001,"publication_date":"2001-05-01","ids":{"openalex":"https://openalex.org/W4406066347","doi":"https://doi.org/10.1016/s0022-3565(24)29584-7","mag":"2103091843","pmid":"https://pubmed.ncbi.nlm.nih.gov/11303057"},"language":"en","primary_location":{"id":"doi:10.1016/s0022-3565(24)29584-7","doi":"https://doi.org/10.1016/s0022-3565(24)29584-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0022-3565(24)29584-7","pdf_url":null,"source":{"id":"https://openalex.org/S102125482","display_name":"Journal of Pharmacology and Experimental Therapeutics","issn_l":"0022-3565","issn":["0022-3565","1521-0103"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pharmacology and Experimental Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070249634","display_name":"Sutthasinee Poonyachoti","orcid":"https://orcid.org/0000-0003-3267-8599","observed_orcids":["https://orcid.org/0000-0003-3267-8599"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sutthasinee Poonyachoti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070230820","display_name":"Philip S. Portoghese","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philip S. Portoghese","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5082818434","display_name":"David R. Brown","orcid":"https://orcid.org/0000-0003-3844-5454","observed_orcids":["https://orcid.org/0000-0003-3844-5454"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David R. Brown","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":null,"fwci":1.1589,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.75467075,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"297","issue":"2","first_page":"672","last_page":"679"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10365","display_name":"Gastrointestinal motility and disorders","score":0.005100000184029341,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/7-benzylidenenaltrexone","display_name":"7-benzylidenenaltrexone","score":0.9549999833106995},{"id":"https://openalex.org/keywords/opioid-receptors","display_name":"opioid receptors","score":0.6290000081062317},{"id":"https://openalex.org/keywords/delta-opioid-receptor","display_name":"delta opioid receptor","score":0.8370000123977661},{"id":"https://openalex.org/keywords/mu-opioid-receptor","display_name":"mu-opioid receptor","score":0.9980000257492065},{"id":"https://openalex.org/keywords/kappa-opioid-receptor","display_name":"kappa opioid receptor","score":0.9459999799728394},{"id":"https://openalex.org/keywords/ileal-mucosa","display_name":"ileal mucosa","score":0.781000018119812},{"id":"https://openalex.org/keywords/short-circuit-current","display_name":"short-circuit current","score":0.8270000219345093},{"id":"https://openalex.org/keywords/anion-secretion","display_name":"anion secretion","score":0.7979999780654907},{"id":"https://openalex.org/keywords/deltorphin-ii","display_name":"deltorphin II","score":0.7120000123977661},{"id":"https://openalex.org/keywords/dpdpe","display_name":"DPDPE","score":0.7639999985694885},{"id":"https://openalex.org/keywords/damgo","display_name":"DAMGO","score":0.9610000252723694},{"id":"https://openalex.org/keywords/enkephalin","display_name":"enkephalin","score":0.7440000176429749},{"id":"https://openalex.org/keywords/opioid-antagonists","display_name":"opioid antagonists","score":0.4779999852180481},{"id":"https://openalex.org/keywords/naltriben","display_name":"naltriben","score":0.652999997138977},{"id":"https://openalex.org/keywords/ctop","display_name":"CTOP","score":0.6370000243186951}],"concepts":[{"id":"https://openalex.org/C17077164","wikidata":"https://www.wikidata.org/wiki/Q1185869","display_name":"Inhibitory postsynaptic potential","level":2,"score":0.8158793449401855},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.7162352800369263},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5886648893356323},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5850809812545776},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5407149791717529},{"id":"https://openalex.org/C2777803847","wikidata":"https://www.wikidata.org/wiki/Q325101","display_name":"Enkephalin","level":4,"score":0.4569145143032074},{"id":"https://openalex.org/C88016717","wikidata":"https://www.wikidata.org/wiki/Q417189","display_name":"Opioid peptide","level":4,"score":0.44631725549697876},{"id":"https://openalex.org/C2779886867","wikidata":"https://www.wikidata.org/wiki/Q421797","display_name":"Opioid receptor","level":4,"score":0.43091708421707153},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.32807016372680664},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.30346304178237915},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14579269289970398}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001597","descriptor_name":"Benzylidene Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004558","descriptor_name":"Electric Stimulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004848","descriptor_name":"Epithelium","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004848","descriptor_name":"Epithelium","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005071","descriptor_name":"Evoked Potentials","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007413","descriptor_name":"Intestinal Mucosa","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007413","descriptor_name":"Intestinal Mucosa","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011957","descriptor_name":"Receptors, Opioid","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D013552","descriptor_name":"Swine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017450","descriptor_name":"Receptors, Opioid, mu","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D017465","descriptor_name":"Receptors, Opioid, delta","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D017473","descriptor_name":"Receptors, Opioid, kappa","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D018613","descriptor_name":"Microscopy, Confocal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/s0022-3565(24)29584-7","doi":"https://doi.org/10.1016/s0022-3565(24)29584-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0022-3565(24)29584-7","pdf_url":null,"source":{"id":"https://openalex.org/S102125482","display_name":"Journal of Pharmacology and Experimental Therapeutics","issn_l":"0022-3565","issn":["0022-3565","1521-0103"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pharmacology and Experimental Therapeutics","raw_type":"journal-article"},{"id":"pmid:11303057","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11303057","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of pharmacology and experimental therapeutics","raw_type":"Journal Article"},{"id":"mag:2103091843","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11303057","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8560000061988831,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4778508862","display_name":"Mucosal Defense Mechanisms in Substance Abuse","funder_award_id":"R01DA010200","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G8881639392","display_name":"Selective Opioid Ligands","funder_award_id":"R01DA001533","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":44,"referenced_works":["https://openalex.org/W56559638","https://openalex.org/W573226132","https://openalex.org/W1501813653","https://openalex.org/W1573791744","https://openalex.org/W1686581241","https://openalex.org/W1862696357","https://openalex.org/W1891097825","https://openalex.org/W1925123343","https://openalex.org/W1960449411","https://openalex.org/W1979572663","https://openalex.org/W2006112766","https://openalex.org/W2006598989","https://openalex.org/W2008435872","https://openalex.org/W2009081930","https://openalex.org/W2031279249","https://openalex.org/W2032536398","https://openalex.org/W2032706785","https://openalex.org/W2033625550","https://openalex.org/W2048920781","https://openalex.org/W2061302346","https://openalex.org/W2062703546","https://openalex.org/W2063895355","https://openalex.org/W2066301942","https://openalex.org/W2068220609","https://openalex.org/W2069755888","https://openalex.org/W2071189031","https://openalex.org/W2077099872","https://openalex.org/W2084282289","https://openalex.org/W2086145765","https://openalex.org/W2096686163","https://openalex.org/W2097154129","https://openalex.org/W2123807794","https://openalex.org/W2130901675","https://openalex.org/W2133181632","https://openalex.org/W2142891679","https://openalex.org/W2169352888","https://openalex.org/W2240878996","https://openalex.org/W2272917555","https://openalex.org/W2275009642","https://openalex.org/W2296943649","https://openalex.org/W2403543477","https://openalex.org/W4297627420","https://openalex.org/W4406054873","https://openalex.org/W4406059054"],"related_works":["https://openalex.org/W7098759000","https://openalex.org/W2075269977","https://openalex.org/W2103091843","https://openalex.org/W4406054873","https://openalex.org/W2022679709","https://openalex.org/W1979572663","https://openalex.org/W1862696357","https://openalex.org/W2422420037","https://openalex.org/W1993421493","https://openalex.org/W2016593118"],"abstract_inverted_index":null,"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2025-01-05T00:00:00"}